Elanco Animal Health Inc (ELAN)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue | 1,241 | 1,193 | 1,030 | 1,184 |
| Cost of sales | 528 | 509 | 492 | 495 |
| Gross profit | 713 | 684 | - | - |
| Amortization of intangible assets | 136 | 128 | 133 | 131 |
| Interest expense, net of capitalized interest | 48 | 40 | - | - |
| Other expense, net | -11 | -12 | - | - |
| Research and development | 92 | 94 | 87 | 89 |
| Asset impairment, restructuring and other special charges | 1 | 9 | 17 | 80 |
| Marketing, selling and administrative | 400 | 341 | 323 | 354 |
| Other expense, net | - | - | -1 | -2 |
| Interest expense, net of capitalized interest | - | - | 58 | 65 |
| Goodwill impairment | - | - | - | - |
| Gain on divestiture | - | - | 640 | - |
| Costs, expenses and other | - | - | 471 | 1,216 |
| Income (loss) before income taxes | 25 | 60 | 559 | -32 |
| Income tax expense (benefit) | 14 | -7 | 195 | 18 |
| Net income (loss) | 11 | 67 | 364 | -50 |
| Basic (in shares) | 496,600,000 | 495,100,000 | 494,300,000 | 494,200,000 |
| Basic (usd per share) | 0.02 | 0.14 | 0.74 | -0.1 |
| Diluted (in shares) | 500,100,000 | 499,100,000 | 497,700,000 | 494,200,000 |
| Diluted (usd per share) | 0.02 | 0.13 | 0.73 | -0.1 |